Tokushima, Japan

Yoji Sakurai

This inventor holds 2 USPTO granted patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoji Sakurai. Retrieved from https://idiyas.com/inventor/yoji-sakurai-nex843r7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yoji Sakurai: Innovator in Neuroprotective Compounds

Introduction

Yoji Sakurai is a prominent inventor based in Tokushima, Japan. He has made significant contributions to the field of neuroprotective compounds, holding a total of 2 patents. His work focuses on developing innovative solutions for nerve cell degeneration and related conditions.

Latest Patents

Sakurai's latest patents include a biphenyl derivative composition aimed at repairing nerve cell degeneration. This composition features a biphenyl derivative formula that serves as a protective agent for nerve cells. Additionally, he has developed novel hydrofluorene derivatives that exhibit excellent activities for improving anoxemic and hypoxic symptoms. These derivatives are not only useful as cerebral activators but also as preventive agents for arrhythmia and heart failure caused by oxygen shortages. Furthermore, they possess antioxidant properties, making them valuable in treating various disturbances caused by excessive active oxygen radicals.

Career Highlights

Yoji Sakurai is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to innovate in the field of pharmaceuticals. His research has led to advancements that have the potential to improve the quality of life for individuals suffering from neurological conditions.

Collaborations

Sakurai has collaborated with notable colleagues, including Tatsuyoshi Tanaka and Hiroshi Okazaki. Their combined expertise has contributed to the success of their research endeavors.

Conclusion

Yoji Sakurai's work in developing neuroprotective compounds showcases his dedication to advancing medical science. His innovative patents reflect a commitment to improving health outcomes for those affected by nerve cell degeneration.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…